Journal of Nuclear Medicine June 2026, jnumed.125.271856; DOI: https://doi.org/10.2967/jnumed.125.271856 ...

Journal of Nuclear Medicine June 2026, jnumed.126.272009; DOI: https://doi.org/10.2967/jnumed.126.272009 ...

Fever of unknown origin (FUO) presents a significant diagnostic challenge because of its wide range of potential causes. The role of [18F]FDG PET/CT in this complex clinical scenario is not yet fully ...

Journal of Nuclear Medicine May 2026, jnumed.126.272191; DOI: https://doi.org/10.2967/jnumed.126.272191 ...

Journal of Nuclear Medicine May 2026, jnumed.125.271093; DOI: https://doi.org/10.2967/jnumed.125.271093 ...

We developed a new C-X-C chemokine receptor 4 (CXCR4)–targeting radiolabeled peptide, [68Ga]Ga/[177Lu]Lu-BL34, using a novel and potent cyclic peptide based on structure–activity relationship studies ...

Journal of Nuclear Medicine March 2026, jnumed.125.271721; DOI: https://doi.org/10.2967/jnumed.125.271721 ...

CD70 represents a promising therapeutic target for lymphoma. The expression patterns of CD70 and the diagnostic value of CD70-targeted immuno-PET/CT in lymphomas remain unknown. Methods: We ...

Journal of Nuclear Medicine February 2026, jnumed.125.271098; DOI: https://doi.org/10.2967/jnumed.125.271098 ...

Journal of Nuclear Medicine January 2026, jnumed.125.269933; DOI: https://doi.org/10.2967/jnumed.125.269933 ...

Journal of Nuclear Medicine January 2026, jnumed.125.271039; DOI: https://doi.org/10.2967/jnumed.125.271039 ...

Journal of Nuclear Medicine January 2026, jnumed.125.271006; DOI: https://doi.org/10.2967/jnumed.125.271006 ...